2. The Novartis LTA4H metalloenzyme inhibitor, LYS006, is a selective oral agent in multiple Ph. II studies to treat inflammatory diseases including ulcerative colitis and NASH. The starting points…
Home > LYS006
this content is exclusive to
Premium members
Unlock this content with a Premium membership to read it now.